Through genomic, transcriptomic, methylomic, and molecular dynamics analyses, the KRAS mutant and the stability of the protein expressed by it could predict the poor prognosis of pancreatic cancer (Kaushik et al., 2021). Here, KRAS is linked to pancreatic neoplasm.